These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

211 related items for PubMed ID: 9815298

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Phase I and II studies of the combination of recombinant human interferon-gamma and 5-fluorouracil in patients with advanced colorectal carcinoma.
    Ajani JA, Rios AA, Ende K, Abbruzzese JL, Edwards C, Faintuch JS, Saks S, Gutterman JU, Levin B.
    J Biol Response Mod; 1989 Apr; 8(2):140-6. PubMed ID: 2499663
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. A pilot study of interferon alpha-2a, fluorouracil, and leucovorin given with granulocyte-macrophage colony stimulating factor in advanced gastrointestinal adenocarcinoma.
    Shapiro JD, Harold N, Takimoto C, Hamilton JM, Vaughn D, Chen A, Steinberg SM, Liewehr D, Allegra C, Monahan B, Lash A, Grollman F, Flemming D, Behan K, Johnston PG, Haller D, Quinn M, Morrison G, Grem JL.
    Clin Cancer Res; 1999 Sep; 5(9):2399-408. PubMed ID: 10499610
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. A phase II randomised trial of 5-fluorouracil with or without interferon alpha-2a in advanced colorectal cancer.
    Piga A, Cascinu S, Latini L, Marcellini M, Bavosi M, Acito L, Bascioni R, Giustini L, Francini G, Pancotti A, Rossi G, Del Papa M, Carle F, Cellerino R.
    Br J Cancer; 1996 Sep; 74(6):971-4. PubMed ID: 8826868
    [Abstract] [Full Text] [Related]

  • 27. Interferon beta increases antitumor activity of 5-fluorouracil against human colon carcinoma cells in vitro and in vivo.
    Kase S, Kubota T, Watanabe M, Furukawa T, Tanino H, Ishibiki K, Teramoto T, Kitajima M.
    Anticancer Res; 1993 Sep; 13(2):369-73. PubMed ID: 8517649
    [Abstract] [Full Text] [Related]

  • 28. A phase II trial of interferon alpha-2b with folinic acid and 5-fluorouracil administered by 4-hour infusion in metastatic colorectal carcinoma.
    Kreuser ED, Hilgenfeld RU, Matthias M, Hoksch B, Boewer C, Oldenkott B, Lenk H, Wiener N, Boese-Landgraf J, Schalhorn A.
    Semin Oncol; 1992 Apr; 19(2 Suppl 4):57-62. PubMed ID: 1553576
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. A phase I trial of interferon alpha-2b with folinic acid and 5-fluorouracil administered by 4-hour infusion in metastatic colorectal carcinoma.
    Kreuser ED, Hilgenfeld RU, Matthias M, Hoksch B, Boewer C, Oldenkott B, Knauf WU, Boese-Landgraf J, Schalhorn A, Zeitz M.
    Semin Oncol; 1992 Apr; 19(2 Suppl 3):197-203. PubMed ID: 1557647
    [Abstract] [Full Text] [Related]

  • 35. High-dose lymphoblastoid interferon in advanced renal cell carcinoma: an Eastern Cooperative Oncology Group Study.
    Trump DL, Elson PJ, Borden EC, Harris JE, Tuttle RL, Whisnant JK, Oken MM, Carignan JR, Ruckdeschel JC, Davis TE.
    Cancer Treat Rep; 1987 Feb; 71(2):165-9. PubMed ID: 3802113
    [Abstract] [Full Text] [Related]

  • 36. Biochemical modulation of 5-fluorouracil by leucovorin with or without interferon-alpha-2c in patients with advanced colorectal cancer: final results of a randomised phase III study.
    Hausmaninger H, Moser R, Samonigg H, Mlineritsch B, Schmidt H, Pecherstorfer M, Fridrik M, Kopf C, Nitsche D, Kaider A, Ludwig H.
    Eur J Cancer; 1999 Mar; 35(3):380-5. PubMed ID: 10448286
    [Abstract] [Full Text] [Related]

  • 37. Phase I study of combination therapy with interleukin 2 and beta-interferon in patients with advanced malignancy.
    Tamura T, Sasaki Y, Shinkai T, Eguchi K, Sakurai M, Fujiwara Y, Nakagawa K, Minato K, Bungo M, Saijo N.
    Cancer Res; 1989 Feb 01; 49(3):730-5. PubMed ID: 2783385
    [Abstract] [Full Text] [Related]

  • 38. 5-FU infusion in advanced colorectal cancer: a comparison of three dose schedules.
    Shah A, MacDonald W, Goldie J, Gudauskas G, Brisebois B.
    Cancer Treat Rep; 1985 Feb 01; 69(7-8):739-42. PubMed ID: 4016784
    [Abstract] [Full Text] [Related]

  • 39. [Administration and dosage of fluorouracil (5-FU) continuous i.v. infusion in patients with non-curative resected/non-resected gastric cancer].
    Yamaguchi A, Isogai M, Hori A, Kawai M, Yamaguchi R, Kubota T, Yamada T, Maeda A.
    Gan To Kagaku Ryoho; 1996 Apr 01; 23(5):567-72. PubMed ID: 8678514
    [Abstract] [Full Text] [Related]

  • 40. Continuous infusion of high-dose 5-fluorouracil in combination with leucovorin and recombinant interferon-alpha-2b in patients with advanced colorectal cancer. A Multicenter Phase II study.
    Punt CJ, Burghouts JT, Croles JJ, van Liessum PA, de Mulder PH, Kamm Y.
    Cancer; 1993 Oct 01; 72(7):2107-11. PubMed ID: 8374869
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.